Clinical trial
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been…
NCT00157248 · Boehringer Ingelheim, Industry · Terminated
Key facts
| NCT number | NCT00157248 |
|---|---|
| Title | Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 |
| Official title | Long-term, Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial (Trial 1160.20 - NCT01227629). (PETRO Extension Trial: PETRO-Ex) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Stroke |
| Intervention type | Drug |
| Interventions | dabigatran etexilate |
| Enrollment | 361 |
| Start date | Dec 1, 2003 |
| Primary completion | Jan 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | May 19, 2014 |
| Countries | Denmark, Netherlands, Sweden, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: